FIELD: veterinary medicine.
SUBSTANCE: group of inventions relates to veterinary medicine, namely to a composition for the treatment or delay of the progression of chronic kidney disease (hereinafter – CKD) in a cat. A dry or wet feed composition for pets contains effective amount of magnesium or its salt selected from acetate salt, TFA salt, formiate salt and glycinate salt for the treatment or delay of the progression of chronic kidney disease (CKD) in a cat in need of it, where the effective amount of magnesium or its salt is in the range between 50 mg/1000 kcal and 500 mg/1000 kcal, and the specified feed composition for pets additionally contains an additional active agent, which is a nutrient. A method for the treatment or delay of the progression of chronic kidney disease (CKD) in a cat (options) is proposed. A method for the diagnostics of a cat at risk of chronic kidney disease (CKD) for further treatment using a dry or wet feed composition for pets is proposed. A method for the treatment of a cat at risk of chronic kidney disease (CKD) is proposed. The use of a dry or wet feed composition for pets is proposed to treat or delay the progression of chronic kidney disease (CKD) in a cat in need of it, where the cat has a magnesium deficiency compared to a given reference value, and where the given reference value is based on the average level of magnesium in the blood of the control population. The use of magnesium levels in the blood as a biomarker for the prediction and/or quantitative description of chronic kidney disease in a cat, with its subsequent treatment, is proposed, where magnesium levels compared to the given reference value provide justification for the need to correct the diet for the treatment of chronic kidney disease in a cat in need of it, including the provision of a dry or wet feed composition for pets. A method for diagnosing chronic kidney disease (CKD) in a cat for further treatment using a dry or wet feed composition for pets is proposed. A method for the treatment of chronic kidney disease (CKD) in a cat is proposed.
EFFECT: above-described composition and method are effective for the treatment or delay of the progression of chronic kidney disease (CKD) in a cat.
31 cl, 7 dwg, 6 tbl, 3 ex
